Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density

Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density

ABSTRACT Objective: To evaluate changes in bone density and architecture in postmenopausal women with breast cancer (BC) and use of aromatase inhibitor (AI). Subjects and methods: Thirty-four postmenopausal women with BC, without bone metastasis, renal function impairment and who were not receivin...

Full description

Bibliographic Details
Main Authors: Frederico Arthur Pereira Nunes, Maria Lucia Fleiuss de Farias, Felipe Peres Oliveira, Leonardo Vieira Neto, Luis Felipe Cardoso Lima, Francisco de Paula Paranhos Neto, Laura Maria Carvalho de Mendonça, Miguel Madeira
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2021-07-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Breast cancer
osteoporosis
aromatase inhibitors (AI)
bone mineral density (BMD)
high resolution peripheral quantitative computed tomography (HR-pQCT)
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000400505&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972021000400505&tlng=en

Similar Items